Rexford Sefah Ahima is a Professor of Medicine, Public Health and Nursing; Bloomberg Distinguished Professor of Diabetes at the Johns Hopkins Medical School; and the Director of the Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University School of Medicine. Ahima's research focuses on central and peripheral actions of adipocyte hormones in energy homeostasis, and glucose and lipid metabolism. Biography Rexford Ahima had his high school education at Accra Academy in Ghana. He gained a Bachelor of Science degree in Endocrinology from the Middlesex Hospital Medical School, University of London. He received his M.D. from the University of Ghana Medical School in 1986 and a Ph.D from Tulane University in New Orleans, Louisiana in 1992. Ahima had his residency training in Internal Medicine at the Albert Einstein College of Medicine, Jack D. Weiler Hospital and Jacobi Medical Center in New York. Ahima did his clinical and research fellowship training in Endocrinology, Diabetes and Metabolism at the Beth Israel Deaconess Medical Center and Harvard Medical School in Boston. At Harvard, he had his research fellowship in the laboratory of Dr. Jeffrey S. Flier, after which he served as an instructor in Medicine at Harvard before moving to the University of Pennsylvania in 1999. He became a tenured Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania and was the Director of Obesity Unit, Institute for Diabetes, Obesity and Metabolism and Director of Diabetes Research Center Mouse Phenotyping Core. In 2016, Ahima joined Johns Hopkins University as a Bloomberg Distinguished Professor of Diabetes with appointments in the School of Medicine, School of Nursing, and Bloomberg School of Public Health. He was also appointed Leader of the Johns Hopkins University Diabetes Initiative and Director of the Division of Endocrinology, Diabetes and Metabolism. Research Dr. Ahima’s laboratory investigates CNS and peripheral actions of adipokines in energy homeostasis, and glucose and lipid metabolism. He has performed seminal studies to define the roles of leptin, adiponectin and resistin in obesity and diabetes using genetic techniques and metabolic phenotyping of mouse models. Moreover, he is involved in clinical and population studies focusing on the pathogenesis of obesity and Diabetes. Awards and distinctions Ahima was elected to the National Academy of Medicine in 2020, the American Society for Clinical Investigation in 2005, the Association of American Physicians in 2010), the Interurban Clinical Club, and a is a fellow of the American Association for